MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCMSOUTH SAN FRANCISCO, Calif., ...
Introduction Demographic change is resulting in a growing number of individuals requiring nursing care, while the ...
Introduction: Survivors of severe COVID-19 (Coronavirus Disease 2019) frequently experience long-term functional impairment, a condition known as post-COVID syndrome. As these patients may eventually ...
SOUTH SAN FRANCISCO, Calif., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food and Drug Administration (FDA) has approved MYQORZO™ ...
Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. In this work, the effect of germination time (4 days) on the proximal composition of ...
ABSTRACT: Background: Amelia, the complete absence of a limb, is a rare congenital anomaly with a complex and multifactorial etiology, including genetic, vascular, and environmental factors. Early ...
Engineering Research Center of Western Resource Innovation Medicine Green Manufacturing, Ministry of Education, School of Chemical Engineering, Northwest University, Xi’an 710069, China Shaanxi R&D ...
Background: The patient’s somatic health status plays an important role in the factors predisposing to the development of depression. Any disease, especially a chronic one, often associated with pain, ...
The following is a summary of “Effect of disopyramide therapy on functional capacity improvement in patients with obstructive hypertrophic cardiomyopathy,” published in the December 2024 issue of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results